1. Int J Obes (Lond). 2020 Feb;44(2):340-352. doi: 10.1038/s41366-019-0458-1.
Epub  2019 Sep 25.

A lower duodenal immune response is associated with an increase of insulin 
resistance in patients with morbid obesity.

Ho-Plagaro A(1)(2)(3), Santiago-Fernandez C(1)(2), García-Serrano S(1)(4)(5), 
Rodriguez C(1)(2), Garrido-Sanchez L(6)(7)(8), Escamilla A(1), Gonzalo M(4), 
Montiel-Casado C(9), Alcaín-Martínez G(1)(2), Garcia-Muñoz B(2), Ruiz-Santana 
N(2), Vázquez-Pedreño L(10), Garcia-Fuentes E(11)(12)(13).

Author information:
(1)Instituto de Investigación Biomédica de Málaga-IBIMA, Málaga, Spain.
(2)Unidad de Gesti ón Clínica de Aparato Digestivo, Hospital Universitario 
Virgen de la Victoria, Málaga, Spain.
(3)Universidad de Málaga, Málaga, Spain.
(4)Unidad de Gestión Clínica de Endocrinología y Nutrición, Hospital Regional 
Universitario de Málaga, Málaga, Spain.
(5)CIBER de Diabetes y Enfermedades Metabólicas Asociadas-CIBERDEM, Málaga, 
Spain.
(6)Instituto de Investigación Biomédica de Málaga-IBIMA, Málaga, Spain. 
lourgarrido@gmail.com.
(7)Unidad de Gestión Clínica de Endocrinología y Nutrición, Hospital 
Universitario Virgen de la Victoria, Málaga, Spain. lourgarrido@gmail.com.
(8)CIBER Fisiología de la Obesidad y Nutrición-CIBEROBN, Málaga, Spain. 
lourgarrido@gmail.com.
(9)Unidad de Gestión Clínica de Cirugía General, Digestiva y Trasplantes, 
Hospital Regional Universitario de Málaga, Málaga, Spain.
(10)Unidad de Gestión Clínica de Aparato Digestivo, Hospital Regional 
Universitario de Málaga, Málaga, Spain.
(11)Instituto de Investigación Biomédica de Málaga-IBIMA, Málaga, Spain. 
edugf1@gmail.com.
(12)Unidad de Gesti ón Clínica de Aparato Digestivo, Hospital Universitario 
Virgen de la Victoria, Málaga, Spain. edugf1@gmail.com.
(13)CIBER Fisiología de la Obesidad y Nutrición-CIBEROBN, Málaga, Spain. 
edugf1@gmail.com.

OBJECTIVE: The intestinal immune response could play an important role in 
obesity-related comorbidities. We aim to study the profile of duodenal cytokines 
and chemokines in patients with morbid obesity (MO), its relation with insulin 
resistance (IR) and the intake of metformin, and with the evolution of MO after 
sleeve gastrectomy (SG).
RESEARCH DESIGN AND METHODS: Duodenal levels of 24 cytokines and 9 chemokines 
were analyzed in 14 nonobese and in 54 MO who underwent SG: with lower IR 
(MO-lower-IR), with higher IR (MO-higher-IR), and with type 2 diabetes treated 
with metformin (MO-metf-T2DM).
RESULTS: MO-lower-IR had higher levels of cytokines related to Th1, Th2, Th9, 
Th17, Th22, M1 macrophages, and chemokines involved in the recruitment of 
macrophages and T-lymphocytes (p < 0.05), and total (CD68 expression) and M1 
macrophages (ITGAX expression) (p < 0.05) when compared with nonobese patients, 
but with a decrease in M2 macrophages (MRC1 expression) (p < 0.05). In 
MO-higher-IR, these chemokines and cytokines decreased and were similar to those 
found in nonobese patients. In MO-metf-T2DM, only IL-4 (Th2) and IL-22 (Th22) 
increased their levels with regard to MO-higher-IR (p < 0.05). In MO-higher-IR 
and MO-metf-T2DM, there was a decrease of CD68 expression (p < 0.05) while ITGAX 
and MRC1 were similar with regard to MO-lower-IR. We found an association 
between CXCL8, TNFβ and IL-2 with the evolution of body mass index (BMI) after 
SG (p < 0.05).
CONCLUSIONS: There is an association between a higher IR and a lower duodenal 
immune response in MO, with a slight increase in those patients with metformin 
treatment. Intestinal immune response could be involved in the evolution of BMI 
after SG.

DOI: 10.1038/s41366-019-0458-1
PMID: 31554917 [Indexed for MEDLINE]
